Exposure–response analysis of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy

AIMS: The relationship between blinatumomab exposure and efficacy endpoints (occurrence of complete remission [CR] and duration of overall survival [OS]) or adverse events (occurrence of cytokine release syndrome [CRS] and neurological events) were investigated in adult patients with relapsed/refrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuchimanchi, Mita, Zhu, Min, Clements, John D., Doshi, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422642/
https://www.ncbi.nlm.nih.gov/pubmed/30645768
http://dx.doi.org/10.1111/bcp.13864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422642/
https://www.ncbi.nlm.nih.gov/pubmed/30645768
http://dx.doi.org/10.1111/bcp.13864

Ejemplares similares